Luxembourg · Delayed Price · Currency is EUR · Price in USD Nectar Lifesciences Company Description
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally.
The company’s active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine.
It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins.
In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
| Country | India |
| Founded | 1995 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 1,686 |
| CEO | Amit Chadah |
Contact Details
Address: SCO 38-39 Chandigarh, 160009 India | |
| Phone | 91 17 2504 7915 |
| Website | neclife.com |
Stock Details
| Ticker Symbol | NECLF |
| Exchange | Luxembourg Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Amit Chadah | Chief Executive Officer |
| Sushil Kapoor | Chief Financial Officer |
| Vikas Vij | Chief Operating Officer |